5,105 followers
New Research: Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection: Background Ceftazidime-avibactam (CAZ-AVI) is a… https://t.co/PigMPOrjqA #PublicH